We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Laryngeal Mask Airway (LMA®) and Tracheal Tube in Modified Radical Mastectomy on Breast Cancer (LMATBBC)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00638599
First Posted: March 19, 2008
Last Update Posted: July 15, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Nanjing Medical University
  Purpose
Airway management in anesthesia is critical to guarantee appropriate treatment of possible respiratory complications and successful operative practice. LMA® is an alternative to tracheal tube in some surgeries like as mastectomy on breast cancer. Given no need using muscular relaxants in mastectomy, the investigators hypothesized that LMA® would be a superior manner in airway management in radical modified mastectomy on breast cancer than the tracheal tube, and the LMA® might produce less influence on patients' circulatory homeostasis, and easier to be placed before operation.

Condition Intervention Phase
Breast Cancer Device: LMA® Device: Endotracheal tube Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Comparison of Laryngeal Mask Airway (LMA®) and Tracheal Tube for Airway Management in Modified Radical Mastectomy on Breast Cancer

Resource links provided by NLM:


Further study details as provided by Nanjing Medical University:

Primary Outcome Measures:
  • Circulatory Homeostasis [ Time Frame: 15min prior to operation to 15min posterior to operation ]

Secondary Outcome Measures:
  • Airway pressure [ Time Frame: 15min prior to operation to 15min posterior to operation ]
  • Blood gas [ Time Frame: 15min prior to operation to 15min posterior to operation ]
  • Airway complications [ Time Frame: Start of operation to 6h after operation ]

Enrollment: 200
Study Start Date: January 2008
Study Completion Date: July 2009
Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
LMA® is placed after anesthesia induction till the end of operation
Device: LMA®
LMA® is placed after anesthesia induction and removed after the operation
Active Comparator: 2
Standard tracheal tube is inserted after anesthesia induction till the end of operation
Device: Endotracheal tube
Standard endotracheal tube is inserted after anesthesia induction and extubated after the operation

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Chinese
  • Diagnosed breast cancer
  • Undergoing modified radical mastectomy
  • Agreed to participate the study with informed contract.

Exclusion Criteria:

  • Organic dysfunction
  • Long-lasting post-anesthetic care unit(PACU) staying.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00638599


Locations
China, Jiangsu
Nanjing Maternal and Child Health Care Hospital
Nanjing, Jiangsu, China, 210004
Sponsors and Collaborators
Nanjing Medical University
Investigators
Study Director: XiaoFeng Shen, MD Nanjing Medical University
  More Information

Responsible Party: XiRong Guo, Nanjing Medical University
ClinicalTrials.gov Identifier: NCT00638599     History of Changes
Other Study ID Numbers: NMU-2579-7FW
NMU075451
First Submitted: March 4, 2008
First Posted: March 19, 2008
Last Update Posted: July 15, 2009
Last Verified: July 2009

Keywords provided by Nanjing Medical University:
Intubation, intratracheal
Homeostasis
Mastectomy, modified radical
Breast Neoplasms

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs